Table 1.
Transition probabilities, unit costs, and utilities used in the analysis
| Parameter | SCRT | LCCRT | Data source |
|---|---|---|---|
| Survival | |||
| 3 year-DFS | 53% | 52% | Bujko et al. [8] |
| 3-year OS | 73% | 65% | Bujko et al. [8] |
| Probabilities (monthly) | |||
| DFS to PD | 0.0204 | 0.0244 | |
| DFS to Death | 0.0148 | 0.0148 | |
| PD to Death | 0.0348 | 0.1020 | |
| Costs per Cycle in US$ | |||
| DFS state | 444.85 | 461.34 | |
| PD state | 4920.50 | 4920.50 | Wen et al. [14] |
| Utility | |||
| DFS state | 0.65 | 0.56 | Ramsey et al. [15] |
| PD state | 0.47 | 0.47 | Wen et al. [14] |
| Death state | 0.00 | 0.00 | |
Abbreviations: SCRT Short-course radiotherapy, LCCRT Long-course chemoradiotherapy, DFS Disease-free survival, OS Overall survival, PD Progressive disease, m median